Journal of Vascular and Interventional Radiology
Volume 21, Issue 3 , Pages 339-347 , March 2010

Utility of C-arm CT in Patients with Hepatocellular Carcinoma undergoing Transhepatic Arterial Chemoembolization

Received 19 April 2009 ,Revised 5 November 2009 ,Accepted 6 November 2009.

References 

  1. American Cancer Society. Cancer facts and figures 2008: American Cancer Society. [updated 2008; cited] http://www.cancer.org/downloads/STT/2008CAFFfinalsecured.pdf2008;Accessed April 21, 2008
  2. Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology. 2002;35:519–524
  3. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology. 1999;30:1434–1440
  4. Yao FY, Bass NM, Nikolai B, et al. Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list. Liver Transpl. 2002;8:873–883
  5. Llovet JM, Mas X, Aponte JJ, et al. Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation. Gut. 2002;50:123–128
  6. Majno PE, Adam R, Bismuth H, et al. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg. 1997;226:688–701discussion 701–683
  7. Graziadei IW, Sandmueller H, Waldenberger P, et al. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. Liver Transpl. 2003;9:557–563
  8. Lo CM, Ngan H, Tso WK, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology. 2002;35:1164–1171
  9. Llovet JM, Real MI, Montana X, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet. 2002;359:1734–1739
  10. Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol. 2004;130:417–422
  11. Arguedas MR, Chen VK, Eloubeidi MA, Fallon MB. Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a cost-utility analysis. Am J Gastroenterol. 2003;98:679–690
  12. Murakami R, Yoshimatsu S, Yamashita Y, Sagara K, Arakawa A, Takahashi M. Transcatheter hepatic subsegmental arterial chemoembolization therapy using iodized oil for small hepatocellular carcinomas: correlation between lipiodol accumulation pattern and local recurrence. Acta Radiol. 1994;35:576–580
  13. Takayasu K, Muramatsu Y, Maeda T, et al. Targeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system: analysis of factors affecting local recurrence and survival rates. AJR Am J Roentgenol. 2001;176:681–688
  14. Kothary N, Weintraub JL, Susman J, Rundback JH. Transarterial chemoembolization for primary hepatocellular carcinoma in patients at high risk. J Vasc Interv Radiol. 2007;18:1517–1526quiz 1527
  15. Ha BY, Ahmed A, Sze DY, et al. Long-term survival of patients with unresectable hepatocellular carcinoma treated with transcatheter arterial chemoinfusion. Aliment Pharmacol Ther. 2007;26:839–846
  16. Kim P, Prapong W, Sze DY, So SK, Razavi MK. Treatment of hepatocellular carcinoma with sub-selective transcatheter arterial oily chemoinfusion. Tech Vasc Interv Radiol. 2002;5:127–131
  17. Wallace MJ, Kuo MD, Glaiberman C, Binkert CA, Orth RC, Soulez G. Three-dimensional C-arm cone-beam CT: applications in the interventional suite. J Vasc Interv Radiol. 2008;19:799–813
  18. Hirota S, Nakao N, Yamamoto S, et al. Cone-beam CT with flat-panel-detector digital angiography system: early experience in abdominal interventional procedures. Cardiovasc Intervent Radiol. 2006;29:1034–1038
  19. Meyer BC, Frericks BB, Albrecht T, Wolf KJ, Wacker FK. Contrast-enhanced abdominal angiographic CT for intra-abdominal tumor embolization: a new tool for vessel and soft tissue visualization. Cardiovasc Intervent Radiol. 2007;30:743–749
  20. Wallace MJ. C-arm computed tomography for guiding hepatic vascular interventions. Tech Vasc Interv Radiol. 2007;10:79–86
  21. Virmani S, Ryu RK, Sato KT, et al. Effect of C-arm angiographic CT on transcatheter arterial chemoembolization of liver tumors. J Vasc Interv Radiol. 2007;18:1305–1309
  22. Fahrig R, Dixon R, Payne T, Morin RL, Ganguly A, Strobel N. Dose and image quality for a cone-beam C-arm CT system. Med Phys. 2006;33:4541–4550
  23. Missler U, Hundt C, Wiesmann M, Mayer T, Bruckmann H. Three-dimensional reconstructed rotational digital subtraction angiography in planning treatment of intracranial aneurysms. Eur Radiol. 2000;10:564–568
  24. Benndorf G, Strother CM, Claus B, et al. Angiographic CT in cerebrovascular stenting. AJNR Am J Neuroradiol. 2005;26:1813–1818
  25. Kakeda S, Korogi Y, Ohnari N, et al. Usefulness of cone-beam volume CT with flat panel detectors in conjunction with catheter angiography for transcatheter arterial embolization. J Vasc Interv Radiol. 2007;18:1508–1516
  26. Sze DY, Strobel N, Fahrig R, Moore T, Busque S, Frisoli JK. Transjugular intrahepatic portosystemic shunt creation in a polycystic liver facilitated by hybrid cross-sectional/angiographic imaging. J Vasc Interv Radiol. 2006;17:711–715
  27. Wallace MJ, Murthy R, Kamat PP, et al. Impact of C-arm CT on hepatic arterial interventions for hepatic malignancies. J Vasc Interv Radiol. 2007;18:1500–1507
  28. Sze DY, Razavi MK, So SK, Jeffrey RB. Impact of multidetector CT hepatic arteriography on the planning of chemoembolization treatment of hepatocellular carcinoma. AJR Am J Roentgenol. 2001;177:1339–1345
  29. Hori M, Murakami T, Kim T, Nakamura H. Diagnosis of hepatic neoplasms using CT arterial portography and CT hepatic arteriography. Tech Vasc Interv Radiol. 2002;5:164–169
  30. Hori M, Murakami T, Oi H, et al. Sensitivity in detection of hypervascular hepatocellular carcinoma by helical CT with intra-arterial injection of contrast medium, and by helical CT and MR imaging with intravenous injection of contrast medium. Acta Radiol. 1998;39:144–151
  31. Kanematsu M, Hoshi H, Murakami T, et al. Detection of hepatocellular carcinoma in patients with cirrhosis: MR imaging versus angiographically assisted helical CT. AJR Am J Roentgenol. 1997;169:1507–1515
  32. Orth RC, Wallace MJ, Kuo MD. C-arm cone-beam CT: general principles and technical considerations for use in interventional radiology. J Vasc Interv Radiol. 2008;19:814–820
  33. Rhee TK, Omary RA, Gates V, et al. The effect of catheter-directed CT angiography on yttrium-90 radioembolization treatment of hepatocellular carcinoma. J Vasc Interv Radiol. 2005;16:1085–1091
  34. Lewandowski RJ, Sato KT, Atassi B, et al. Radioembolization with 90Y microspheres: angiographic and technical considerations. Cardiovasc Intervent Radiol. 2007;30:571–592

 A.T. and N.K. have research grants from Siemens Healthcare. None of the other authors have identified a conflict of interest.

 From the 2009 SIR annual meeting.

PII: S1051-0443(09)01139-7

doi: 10.1016/j.jvir.2009.11.007

Journal of Vascular and Interventional Radiology
Volume 21, Issue 3 , Pages 339-347 , March 2010